Our findings also reveal that suppression of USP10‐B7‐H4 proteolytic axis was effective in resensitizing SG killing efficacy and reducing tumor growth, especially for the tumors with the USP10high/B7‐H7high signature. Here, USP10 is linked to neoplasm.